{"pub": "wsj", "url": "https://wsj.com/articles/j-j-offers-4-billion-opioid-litigation-settlement-11571247596?mod=rsswn", "downloaded_at": "2019-10-16 20:46:53.531494+00:00", "title": "J&J Offers $4 Billion Opioid Litigation Settlement", "language": "en", "text": "Johnson & Johnson has offered to pay about $4 billion to settle all lawsuits in the U.S. accusing the company of contributing to the opioid-addiction epidemic, according to people familiar with the matter.\n\nIf completed, the deal would resolve more than 2,000 lawsuits by state and local governments alleging that J&J\u2019s marketing of pain drugs including Duragesic and Nucynta fueled the opioid crisis. J&J sold the U.S. rights to Nucynta to another company in 2015. The suits also allege that J&J is culpable for...", "description": "Johnson & Johnson has offered to pay about $4 billion to settle all lawsuits in the U.S. accusing the company of contributing to the opioid-addiction epidemic, according to people familiar with the matter.", "authors": ["Peter Loftus", "Sara Randazzo", "Peter.Loftus Dowjones.Com", "Sara.Randazzo Wsj.Com"], "top_image": "https://images.wsj.net/im-117618/social", "published_at": "2019-10-16"}